Table 3. Age, MVD/CD105, Karnofsky score, survival in individual CD44 groups (Kruskal-Wallis test).
CD44 group | n | Arithmetic mean | SD | Min | Max | Percentile | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
25th | Median | 75th | |||||||||||
Age | 0-45 | 12 | 65.17 | 8.89 | 47.00 | 77.00 | 57.25 | 67.50 | 70.75 | ||||
46-75 | 24 | 60.50 | 9.51 | 48.00 | 77.00 | 51.75 | 60.00 | 68.75 | |||||
76-100 | 19 | 63.58 | 9.00 | 49.00 | 75.00 | 55.00 | 65.00 | 72.00 | |||||
MVD/CD105 | 0-45 | 12 | 14.56 | 8.10 | 6.00 | 32.00 | 8.42 | 11.50 | 21.58 | ||||
46-75 | 24 | 14.19 | 5.96 | 3.67 | 24.67 | 10.00 | 12.50 | 20.08 | |||||
76-100 | 19 | 18.16 | 11.94 | 6.67 | 52.33 | 8.78 | 13.00 | 22.67 | |||||
Karnofsky score | 0-45 | 12 | 74.17 | 22.75 | 40.00 | 100.00 | 52.50 | 70.00 | 100.00 | ||||
46-75 | 24 | 78.75 | 19.85 | 40.00 | 100.00 | 62.50 | 85.00 | 97.50 | |||||
76-100 | 19 | 72.11 | 21.49 | 40.00 | 100.00 | 50.00 | 80.00 | 90.00 | |||||
Survival (days)* | 0-45 | 12 | 185.67 | 142.00 | 7.00 | 477.00 | 74.00 | 173.50 | 271.25 | ||||
46-75 | 24 | 234.42 | 142.93 | 23.00 | 512.00 | 126.00 | 208.50 | 370.50 | |||||
76-100 | 19 | 118.74 | 82.98 | 13.00 | 352.00 | 59.00 | 121.00 | 151.00 | |||||
Kruskal Wallis test | df | p | |||||||||||
Age | 2.00 | 2 | 0.367 | ||||||||||
MVD/CD105 | 0.89 | 2 | 0.641 | ||||||||||
Karnofsky score | 1.10 | 2 | 0.577 | ||||||||||
Survival (days) | 8.19 | 2 | 0.017 |
*Kendall’s tau_b; MVD = microvascular density; figures in bold are statistically significant